Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads - Yang - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Part:BBa K4040015 - parts.igem.org
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
CD19 MicroBeads, human | CD19 Microbeads | human | Products | Miltenyi Biotec | USA
Human CD19 Magnetic Beads Kit KMS004 | Proteintech
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy Methods & Clinical Development
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion | Leukemia
Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients | ACS Synthetic Biology
Simplified process for the production of anti–CD19-CAR–engineered T cells - Cytotherapy
Anti-rabbit CD19 Recombinant Antibody – Cobalt Biologics
Anti-Human CD19 Magnetic Particles - DM
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications - Cytotherapy
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T... | Download Scientific Diagram
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture
Human CD19 Separation Beads | Biocompare.com Kit/Reagent Review
Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells: Molecular Therapy Methods & Clinical Development
CD19 Positive Cell Isolation Kit
Beads for Research | ProMab
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
FITC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Human CD19 Magnetic Beads MS005 | Proteintech
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
